XML 23 R42.htm IDEA: XBRL DOCUMENT v3.19.3
Segment Reporting (Tables)
9 Months Ended
Sep. 30, 2019
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information by Segment
Three months ended September 30, 2019
 
Food, Health and Nutrition
 
Industrial Specialties
 
Other
 
Total
Net sales
 
$
105,174


$
73,141


$
11,034


$
189,349

EBITDA
 
$
14,791


$
8,861


$
792


$
24,444

Depreciation and amortization expense
 
$
6,959


$
3,768


$
403


$
11,130

 
 
 
 
 
 
 
 
 
Three months ended September 30, 2018
 
Food, Health and Nutrition
 
Industrial Specialties
 
Other
 
Total
Net sales
 
$
115,132

 
$
65,667

 
$
16,135

 
$
196,934

EBITDA
 
$
14,563

 
$
8,885

 
$
2,424

 
$
25,872

Depreciation and amortization expense
 
$
7,142

 
$
3,153

 
$
569

 
$
10,864

 
 
 
 
 
 
 
 
 
Nine Months Ended September 30, 2019
 
Food, Health and Nutrition
 
Industrial Specialties
 
Other
 
Total
Net sales
 
$
326,783

 
$
204,064

 
$
34,954

 
$
565,801

EBITDA
 
$
48,758

 
$
23,891

 
$
3,833

 
$
76,482

Depreciation and amortization expense
 
$
20,128

 
$
10,714

 
$
934

 
$
31,776

 
 
 
 
 
 
 
 
 
Nine Months Ended September 30, 2018
 
Food, Health and Nutrition
 
Industrial Specialties
 
Other
 
Total
Net sales
 
$
367,159

 
$
195,767

 
$
46,173

 
$
609,099

EBITDA
 
$
48,494

 
$
26,772

 
$
2,987

 
$
78,253

Depreciation and amortization expense
 
$
21,677

 
$
10,257

 
$
1,383

 
$
33,317


Reconciliation of Net Income to EBITDA
A reconciliation of net income to EBITDA follows:
 
 
Three months ended
 
 
September 30,
2019
 
September 30,
2018
Net income
 
$
6,451

 
$
14,090

Provision for income taxes
 
2,873

 
(2,510
)
Interest expense, net
 
3,990

 
3,428

Depreciation and amortization
 
11,130

 
10,864

EBITDA
 
$
24,444

 
$
25,872

 
 
 
 
 
 
 
Nine months ended
 
 
September 30,
2019
 
September 30,
2018
Net income
 
$
16,546

 
$
31,251

Provision for income taxes
 
16,580

 
4,155

Interest expense, net
 
11,580

 
9,530

Depreciation and amortization
 
31,776

 
33,317

EBITDA
 
$
76,482

 
$
78,253